Ryan Fukushima Sells 14,286 Shares of Tempus AI (NASDAQ:TEM) Stock

Tempus AI, Inc. (NASDAQ:TEM) CEO Ryan Fukushima sold 14,286 shares of the stock in a transaction on Friday, August 21st. The stock was sold at an average price of $70.00, for a total value of $1,000,020.00. Following the transaction, the chief executive officer owned 47,420 shares in the company, valued at $3,319,400. The trade was a 23.15% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Ryan Fukushima also recently made the following trade(s):

• On Tuesday, August 18th, Ryan Fukushima sold 41,095 shares of Tempus AI stock. The shares were sold at an average price of $49.61, for a total transaction of $2,038,722.95.
• On Friday, August 7th, Ryan Fukushima sold 20,000 shares of Tempus AI stock. The shares were sold at an average price of $50.04, for a total transaction of $1,000,800.00.
• On Monday, August 3rd, Ryan Fukushima sold 23,818 shares of Tempus AI stock. The stock was sold at an average price of $46.19, for a total transaction of $1,100,153.42.
• On Wednesday, July 8th, Ryan Fukushima sold 33,284 shares of Tempus AI stock. The shares were sold at an average price of $57.39, for a total transaction of $1,910,168.76.
• On Monday, July 6th, Ryan Fukushima sold 10,000 shares of Tempus AI stock. The stock was sold at an average price of $60.00, for a total transaction of $600,000.00.

Tempus AI Price Performance

NASDAQ:TEM traded up $2.56 during mid-day trading on Tuesday, reaching $68.73. The stock had a trading volume of 8,855,085 shares, compared to its average volume of 6,061,404. The company has a debt-to-equity ratio of 3.06, a current ratio of 3.30 and a quick ratio of 3.16. Tempus AI, Inc. has a 12 month low of $40.77 and a 12 month high of $104.32. The stock has a market capitalization of $12.40 billion, a PE ratio of -47.73 and a beta of 3.58. The stock has a 50-day simple moving average of $53.21 and a two-hundred day simple moving average of $51.38.

Tempus AI (NASDAQ:TEM) last released its quarterly earnings data on Thursday, July 30th. The company reported ($0.04) earnings per share for the quarter, beating the consensus estimate of ($0.14) by $0.10. Tempus AI had a negative return on equity of 50.28% and a negative net margin of 17.77%.The business had revenue of $382.49 million for the quarter, compared to analyst estimates of $379.69 million. During the same period last year, the firm posted ($0.22) earnings per share. Tempus AI’s revenue was up 21.6% compared to the same quarter last year. On average, equities analysts anticipate that Tempus AI, Inc. will post -1.38 earnings per share for the current year.

Institutional Trading of Tempus AI

Several institutional investors have recently modified their holdings of the business. JPL Wealth Management LLC acquired a new stake in Tempus AI in the third quarter valued at $26,000. Los Angeles Capital Management LLC bought a new stake in shares of Tempus AI in the 4th quarter valued at about $27,000. Harvest Fund Management Co. Ltd bought a new stake in shares of Tempus AI in the 3rd quarter valued at about $38,000. EMC Capital Management acquired a new stake in shares of Tempus AI in the second quarter valued at about $29,000. Finally, Danske Bank A S acquired a new stake in shares of Tempus AI in the third quarter valued at about $48,000. Institutional investors own 24.22% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities analysts recently issued reports on TEM shares. Wolfe Research started coverage on shares of Tempus AI in a research report on Tuesday, June 2nd. They set a “peer perform” rating for the company. TD Cowen reaffirmed a “buy” rating on shares of Tempus AI in a research note on Wednesday, July 15th. Weiss Ratings upgraded shares of Tempus AI from a “sell (e+)” rating to a “sell (d-)” rating in a report on Wednesday, August 12th. BTIG Research increased their price target on Tempus AI from $70.00 to $80.00 and gave the company a “buy” rating in a research note on Thursday, August 20th. Finally, Piper Sandler cut their price objective on Tempus AI from $58.00 to $56.00 and set a “neutral” rating on the stock in a report on Tuesday, August 4th. Nine investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and two have given a Sell rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $65.69.

Tempus AI Company Profile

Tempus is a technology-driven healthcare company that applies artificial intelligence and machine learning to clinical and molecular data in order to advance precision medicine. Its primary focus lies in oncology, where the company offers comprehensive genomic profiling, digital pathology services and data-driven insights to inform personalized cancer care. By integrating DNA and RNA sequencing with structured clinical information, Tempus enables clinicians and researchers to identify targeted treatment options for patients based on the genetic characteristics of their tumors.

The company’s core offering centers on a scalable, cloud-based analytics platform that aggregates vast amounts of molecular and clinical data.